Answers are grounded in this paper and cite their sources.
Evidence is mounting that circulating tumor deoxyribonucleic acid can be tested accurately, frequently, and in a noninvasive form. Its role in monitoring patients with cancer, particularly colorectal cancer, is increasing. In this brief review, we discuss its current role when measured using next-generation sequencing-based methods.
No takes yet. Share an insight, caveat, or question.
Rathnasamy et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: